{"nct_id":"NCT02256436","title":"A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2014-10-22","start_date_type":"ACTUAL","primary_completion_date":"2016-09-07","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}